This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue.

      

You are about to leave a GSK website

Third party content disclaimers

 

You are about to leave a GSK website. By clicking this link, you will be taken to a website that is independently operated and not managed by GSK. The website you are linking to is not controlled or endorsed by GSK and GSK assumes no responsibility for the content on the website. If you wish to proceed, click "OK". If you do not wish to leave this website, click “CANCEL”.

OK

CANCEL

451 results

A Europe-wide appraisal of national guidelines for AOM

01-06-2021
National guidelines for the management of acute otitis media (AOM) play a vital role in antibiotic stewardship (ABS). This review evaluates European guidelines for AOM in children based on methodological quality, Strength of Recommendations and consideration of ABS. While major similarities were found, the authors encourage development of centrally produced, locally adapted AOM guidelines to reduce unnecessary administration of antibiotics.

When are antibiotics appropriate in ARS?

01-06-2021
In North America, acute rhinosinusitis (ARS) is a major driver of antibiotic consumption. Prescribers are encouraged to revisit diagnostic criteria for acute bacterial rhinosinusitis (ABRS) when evaluating patients with ARS, to help identify those who require antibiotics, and prescribe the most appropriate antibiotic treatment.

Developing quality indicators to improve quality of care in ABRS

01-06-2021
Quality indicators (QIs) are an initial step toward improving the quality of care provided to patients. Acute bacterial rhinosinusitis (ABRS), a complication of upper respiratory tract infections (URTIs), lacks specifi c QIs. This study proposes 7 ABRS specific QIs to evaluate the diagnosis and management that reduces symptoms, improves quality of life, and prevents complications.

Evaluating Antibiotics commonly prescribed in paediatric CA-RTIs

01-06-2021
Acute otitis media (AOM), acute bacterial rhinosinusitis (ABRS) and the lower respiratory tract infection, community-acquired pneumonia (CAP), are often treated with antibiotics. This paper evaluates the pharmacological properties of the preferred agents, amoxicillin and amoxicillin + clavulanic acid, compared with oral cephalosporins also prescribed in AOM, ABRS, and CAP. The analysis revealed that oral cephalosporins provide unnecessarily broad spectra of activity.

Homepage

GSKpro is exclusively created for healthcare professionals to provide GSK product related information, services and support.

Fluarix Tetra

Inactivated quadrivalent influenza vaccine <br> Vaccines

Keppra

Levetiracetam<br> Neurology

Ventolin

Salbutamol<br> Respiratory

Cutivate

Fluticasone-propionate<br> Dermatology

Lamictal

Lamotrigine<br> Neurology

Anoro Ellipta

Umeclidinium/Vilanterol<br> Respiratory

Relvar Ellipta

Fluticasone furoate/Vilanterol inhalation powder<br> Respiratory

Tivicay

Dolutegravir<br> HIV

Zyrtec

Cetirizine dihydrochloride<br>Allergy

Duodart

Dutasteride/Tamsulosin hydrochloride<br> Urology

Seretide

Salmeterol/Fluticasone propionate<br> Respiratory

Anoro vs. Tiotropium

Anoro vs. Tiotropium

Head to Head Anoro vs tiotropium

Only Anoro has positive head-to-head data vs. Spiolto

Search Results

GlaxoSmithKline (GSK) UK healthcare professional website search results.

IMD

Discussing Vaccination

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.

Avamys

Fluticasone furoate<br> Allergy

Avamys

Fluticasone furoate<br> Allergy

Keppra

Levetiracetam<br> Neurology

Combination Therapy - Sexual Function Study

BPH | GSK Pharma | Healthcare Professionals

Combination Therapy - Immediate_initiation_of_combination_therapy

BPH | GSK Pharma | Healthcare Professionals

Combination Therapy - Gsk Commitment To BPH

BPH | GSK Pharma | Healthcare Professionals

Combination Therapy - Efficacy

BPH | GSK Pharma | Healthcare Professionals

Combination Therapy - Safety

BPH | GSK Pharma | Healthcare Professionals

PSA Interpretation

BPH | GSK Pharma | Healthcare Professionals

BPH Disease - Pathophysiology

BPH | GSK Pharma | Healthcare Professionals

BPH Disease - Diagosis

BPH | GSK Pharma | Healthcare Professionals

Product - Duodart

BPH | GSK Pharma | Healthcare Professionals

Product - Avodart

BPH | GSK Pharma | Healthcare Professionals

Resources - Expert Views

BPH | GSK Pharma | Healthcare Professionals

Resources -Patient Support Materials

BPH | GSK Pharma | Healthcare Professionals

BPH-mt

BPH | GSK Pharma | Healthcare Professionals

Twinrix

Inactivated hepatitis A and rDNA hepatitis B vaccine(adsorbed)</br> Vaccines

Menveo | Home

Meningococcal Group A,C,W135 & Y Conjugate Vaccine <br> Vaccines

Menveo | Why Menveo

Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine

Safety

Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine

Menveo | Resources

Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine

Menveo | Dosing and Administration

Vaccines | Menveo | Meningococcal Group A, C, W135 & Y Conjugate Vaccine

Varilrix

Varicella-zoster vaccine (live, attenuated)<br> Vaccines

Ancillary structural

An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).

Ancillary structural

An overview of clinical data for Anoro Ellipta (umeclidinium/vilanterol).

Guideline-defined asthma control

Guideline-defined control page for Seretide Adult

Guideline-defined asthma control

Guideline-defined control page for Seretide Adult

Keppra WWE | GSK Pharma | Healthcare Professionals

Keppra (levetiracetam) | A page detailing the reasons why an anti-epileptic drug (AED) choice in women with epilepsy is important.

Asthma Disease

Information for healthcare professionals about asthma, how it impacts patients and treatment goals

Respiratory

A comprehensive source of respiratory information and services, designed to help you support your patients.

Synflorix-impact-around-the-world

Impact around the world. Real-world impact on overall IPD: no notable difference between higher-valent PCVs

Sweden Comparable Impact of PCVs

Sweden: Comparable impact of PCVs. Real-world impact on overall IPD: no significant difference between higher-valent PCVs

Video Center

Welcome to our Synflorix Video Center for HCPs

Healthy Aging

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries. Healthy aging overview.

Pertussis

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries

BPH

HIV

Duodart

(dutasteride/tamsulosin HCL) Capsules <br> Urology

Fluarix Tetra

Inactivated quadrivalent influenza vaccine<br> Vaccines

Particle size

Particle size page for Seretide Adult

Twinrix

Hepatitis A(Inactivated) and Hepatitis B (rDNA) (HAB) vaccine(adsorbed)<br> Vaccines

Expert Videos

GSK Vaccines Expert Videos

Menveo

Meningococcal Group A,C,W135 & Y Conjugate Vaccine<br> Vaccines

Boostrix

tetanus, diphtheria, acellular pertussis vaccine <br> Vaccines

Guideline recommendations

Keppra (levetiracetam) | The Keppra Story | Guideline recommendations |

Expert Videos

GSK Vaccines Expert Videos

World Immunization Week 2020

We provide healthcare professionals in Malaysia with relevant information on GSK products and related therapy areas, events and educational content designed for HCPs.

HCP Resources

Educational resources and guides designed to help healthcare professionals support their patients.

Synflorix

Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines

Vaccination

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.

Dermatology

Information about our classic respiratory portfolio and other resources designed to help healthcare professionals support their patients.

Synflorix

Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines

Safety

The safety of SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) was extensively studied in 2 large phase 3 clinical trials

Arexvy | Q&A

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

PHiD-CV Impact

PHiD-CV Impact

Vaccines

Our Vaccines business is one of the largest in the world, developing, producing and distributing over 2 million vaccines every day to people across 170 countries.

Synflorix

Pneumococcal polysaccharide and non-typeable haemophilus influenzae (NTHi) protein D conjugate vaccine, adsorbed<br> Vaccines

Arexvy | Storage

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Arexvy | Vaccine Design

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Arexvy | Administration

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Master 6

Master 6

homepage

amoxicillin-clavulanate<br>Anti infectives

Zyrtec

Cetirizine dihydrochloride </br> Allergy

Shingrix

Herpes zoster </br> Vaccines

Nucala

Mepolizumab </br> Respiratory

Benlysta

Belimumab<br>Specialty Care

Tivicay

Dolutegravir </br> HIV

HIV Landscape

dolutegravir

Boostrix

Tetanus, diphtheria, acellular pertussis vaccine <br> Vaccines

Arexvy | Secondary Analyses

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Arexvy | Safety

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Arexvy | Efficacy and Safety

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Arexvy | GSKpro Malaysia

AREXVY is indicated for active immunisation for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus in adults 60 years of age and older.

Knowledge Hub

Knowledge Hub

Augmentin

Amoxicillin/Clavulanic acid<br/> Anti-Infectives

Arexvy

Respiratory syncytial virus vaccine (adults)<br>Vaccines

Anoro | GSKpro Malaysia

umeclidinium bromide/vilanterol

Anoro

Umeclidinium/Vilanterol<br> Respiratory

Safety

dolutegravir

Apretude

Cabotegravir<br>HIV

Anoro Guidelines | GSKpro Malaysia

umeclidinium bromide/vilanterol

Seretide

Salmeterol xinafoate / Fluticasone propionate<br> Respiratory

Keppra | Efficacy of ASMs

Keppra, epilepsy, CNS, seizures, type of epilepsy, efficacy, efficacy keppra, Efficacy ASMs, ILAE report

Seretide Evohaler

Seretide MDI page for Seretide Adult

Seretide Accuhaler

Seretide Diskus page for Seretide Adult

Recognition

Recognition page for Seretide Adult

Resources

Keppra (levetiracetam) | Resources | Watch informational videos and webcasts by experts

Keppra | Diagnosis

Keppra, epilepsy, CNS, seizures, type of epilepsy, diagnosis of epilepsy, anti seizure medication, anti epileptic drug, SUDEP, brain and heart, managing epilepsy, focal epilepsy

Visible and invisible symptoms of asthma

Visible and invisible symptoms page for Seretide Adult

Guideline-defined asthma control

Guideline-defined control page for Seretide Adult

Seretide Safety Profile | GSK Pharma

Safety page for Seretide Adult

Keppra

Levetiracetam<br> Neurology

Publications

Publications

MERIT Study

fluticasone propionate/salmeterol

Symptoms and exacerbations

symptoms and exacerbations page for Seretide Adult

Sustained asthma control

Sustained asthma control page for Seretide Adult

New Versus Old: Study Overview

New Versus Old: Study Overview

Rotarix | Homepage

This page contains an overview of the Rotarix platform

Anoro | GSKpro Malaysia

umeclidinium bromide/vilanterol

Asthma Insider

Asthma Insider

Shingles Action Week Infographic

Shingles Action Week Infographic 2026 MY

Guidelines

Augmentin Guidelines

Video Replays

Video Replays

Shingrix | GSKpro Malaysia

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) product information and resources to support HCPs in their daily practice.

Resources

This page contains an overview of the Rotarix platform

Overview

fluticasone furoate<br>Respiratory

Safety & Dosing

Information on the Safety & Dosing of Avamys, high receptor affinity, tissue retention, pharmacodynamic profile and bioavailability

Guidelines

A summary of how positively Avamys (fluticasone furoate) is regarded in international guidelines

Classifying AR

A page detailing Avamys efficacy vs MFNS. Avamys has preferable sensory attributes compared to MFNS.

Device

A page on Avamys Device’s Efficacy. Avamys is delivered with a once-daily gentle fine mist via a patient-friendly, easy-to-use device.

Comparison

A page detailing Avamys Comparison. Avamys has preferable sensory attributes compared to MFNS.

Avamys

Fluticasone furoate<br> Allergy

Rotarix

Rotavirus Vaccine (Live Attenuated, Oral) IP<br> Vaccines

Xyzal

Levocetirizine dihydrochloride<br> Allergy

Overview

Dutasteride/Tamsulosin hydrochloride <br> Urology

PHN Reduction

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) nearly eliminates the risk of developing PHN by preventing shingles

Efficacy

SHINGRIX delivered >90% efficacy against shingles in all age segments ≥50 years old

Scientific Rationale

Recommend the shingles vaccine specifically formulated to address age-related decline in immunity

Shingrix | Guidelines

SHINGRIX (Zoster Vaccine Recombinant, Adjuvanted) is recommended by the CDC for the prevention of shingles (herpes zoster) and related complications for immunocompetent adults aged ≥50 years.

MOA

Home

Homepage

Shingrix | Shingles Disease

Patients ≥50 years old are at risk for shingles, no matter how healthy they may feel

ZEJULA (niraparib) Dosing in NOVA

niraparib<br>ZEJULA's adjustable dosing maintains efficacy and enables long-term treatment

ZEJULA (niraparib) gBRCAm patient profiles

niraparib<br>Benefits of ZEJULA in gBRCAm patients

ZEJULA (niraparib) Efficacy in NOVA

niraparib<br>Durable efficacy with ZEJULA in patients with recurrent ovarian cancer

ZEJULA (niraparib) Safety in NOVA

niraparib<br>ZEJULA has a well-established long-term safety and tolerability profile

ZEJULA (niraparib) BRCAm patient profiles

niraparib<br>Benefits of ZEJULA in 𝘉𝘙𝘊𝘈m patients

ZEJULA (niraparib) HRd Patient Profile

niraparib<br>Benefits of ZEJULA in HRd BRCAwt patients

ZEJULA (niraparib) Recurrent Ovarian Cancer

niraparib<br>ZEJULA is an established choice in second-line maintenance

ZEJULA (niraparib) Dosing in PRIMA

niraparib<br>Once-daily individualised dose with ZEJULA in first-line maintenance

ZEJULA (niraparib) Efficacy in PRIMA

niraparib<br>Proven efficacy with ZEJULA in patients with advanced ovarian cancer

ZEJULA (niraparib) Safety in PRIMA

niraparib<br>ZEJULA offers an established safety and tolerability profile

ZEJULA (niraparib) Advanced Ovarian Cancer

niraparib<br>ZEJULA is now approved in first-line maintenance

Zejula

Niraparib<br> Oncology

Bexsero

Meningococcal group B Vaccine (rDNA, component, adsorbed) <br>Vaccines

Relvar

fluticasone furoate/vilanterol<br> Respiratory

No results. Why not try:

  • Checking the spelling of the search term
  • Trying a different search term
  • Resetting or revising the filter settings (if you used filters to do this search)

show more